COSTE DE LA DIARREA ASOCIADA A CLOSTRIDIUM DIFFICILE EN ESPAÑA

by Ángel Asensio, Emilio Bouza, Santiago Grau, Darío Rubio-Rodríguez, Carlos Rubio-Terrés
Published 2013-01-01

Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain

by Carlos Rubio-Terrés, Ruth Graefenhain de Codes, Darío Rubio-Rodríguez, Thomas Evers, Santiago Grau Cerrato

Cost-effectiveness Analysis of Rituximab Maintenance Treatment in Patients With Follicular Lymphoma who Respond to First Line Induction Therapy in Portugal

by Susana Carvalho, Marília Gomes, Herlander Marques, Catarina Pereira, Darío Rubio-Rodríguez, Carlos Rubio-Terrés, Carlos Sottomayor
Published 2016-01-01

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell T...

by Santiago Grau, Carlos Solano, Carol García-Vidal, Isidro Jarque, Jon A. Barrueta, Carmen Peral, Irene Rodríguez, Darío Rubio-Rodríguez, Carlos Rubio-Terrés

Evaluación económica de la monoterapia con tocilizumab frente a adalimumab en artritis reumatoide

by Federico Navarro Sarabia, Francisco J Blanco, José Mª Álvaro Gracia, Juan A García Meijide, José Luis Poveda, Darío Rubio-Rodríguez, Carlos Rubio-Terrés
Published 2013-01-01

Análisis coste-utilidad de apixabán frente al ácido acetilsalicílico en la prevención del ictus en pacientes con fibrilación auricular no valvular en España

by Ginés Escolar-Albaladejo, Gonzalo Barón-Esquivias, José Luis Zamorano, Lourdes Betegón-Nicolás, Cristina Canal-Fontcuberta, Marina de Salas-Cansado, Darío Rubio-Rodríguez, Carlos Rubio-Terrés
Published 2016-06-01